A. Signori-Schmuck

发表

Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0

V. Thibault, S. Larrat, P. Morand, 2013, Journal of Clinical Microbiology.

Ultra-deep pyro-sequencing of NS3 to predict response to triple therapy with

J. Claude, R. Beugnot, S. Larrat, 2014 .

HIV-1 Load Comparison Using Four Commercial Real-Time Assays

R. Écochard, P. André, B. Pozzetto, 2010, Journal of Clinical Microbiology.

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

V. Calvez, C. Delaugerre, S. Yerly, 2017, The Journal of antimicrobial chemotherapy.

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.

V. Calvez, C. Delaugerre, S. Yerly, 2015, The Journal of antimicrobial chemotherapy.

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.

V. Calvez, C. Charpentier, C. Delaugerre, 2015, The Journal of antimicrobial chemotherapy.

Ultradeep Pyrosequencing of NS3 To Predict Response to Triple Therapy with Protease Inhibitors in Previously Treated Chronic Hepatitis C Patients

M. Blum, J. Claude, R. Beugnot, 2014, Journal of Clinical Microbiology.

Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

Philippe Flandre, Vincent Calvez, Jacques Izopet, 2008, Antimicrobial Agents and Chemotherapy.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network

F. Brun-Vézinet, B. Masquelier, C. Rouzioux, 2007, Antiviral therapy.

Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.

M. Blum, S. Larrat, P. Morand, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

P. André, J. Pawlotsky, J. Izopet, 2017, PloS one.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

P. André, J. Pawlotsky, S. Bertrais, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

V. Calvez, C. Delaugerre, S. Yerly, 2013, International journal of antimicrobial agents.

Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture.

J. Quesada, M. Baccard, S. Larrat, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

V. Calvez, P. Bellecave, D. Descamps, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients

V. Calvez, C. Charpentier, C. Delaugerre, 2009, Antimicrobial Agents and Chemotherapy.

Emerging Mutations and Associated Factors in Patients Displaying Treatment Failure on An Etravirine-Containing Regimen

V. Calvez, C. Delaugerre, B. Masquelier, 2012, Antiviral therapy.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.